Bausch Health Companies Inc.
BHC.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.66B | 2.50B | 2.23B | 2.53B | 2.48B |
| Total Other Revenue | 24.00M | 26.00M | 32.00M | 31.00M | 28.00M |
| Total Revenue | 2.68B | 2.53B | 2.26B | 2.56B | 2.51B |
| Cost of Revenue | 750.00M | 764.00M | 701.00M | 727.00M | 696.00M |
| Gross Profit | 1.93B | 1.77B | 1.56B | 1.83B | 1.81B |
| SG&A Expenses | 795.00M | 894.00M | 862.00M | 816.00M | 850.00M |
| Depreciation & Amortization | 253.00M | 256.00M | 256.00M | 259.00M | 274.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.96B | 2.07B | 1.96B | 1.97B | 1.97B |
| Operating Income | 717.00M | 457.00M | 297.00M | 594.00M | 544.00M |
| Income Before Tax | 218.00M | 140.00M | -47.00M | 209.00M | -21.00M |
| Income Tax Expenses | 37.00M | 12.00M | 39.00M | 111.00M | 71.00M |
| Earnings from Continuing Operations | 181.00M | 128.00M | -86.00M | 98.00M | -92.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | 20.00M | 28.00M | -5.00M | 7.00M |
| Net Income | 179.00M | 148.00M | -58.00M | 93.00M | -85.00M |
| EBIT | 717.00M | 457.00M | 297.00M | 594.00M | 544.00M |
| EBITDA | 1.02B | 764.00M | 602.00M | 901.00M | 866.00M |
| EPS Basic | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 |
| Normalized Basic EPS | 0.52 | 0.01 | 0.03 | 0.40 | 0.37 |
| EPS Diluted | 0.48 | 0.40 | -0.16 | 0.25 | -0.23 |
| Normalized Diluted EPS | 0.52 | 0.01 | 0.03 | 0.40 | 0.37 |
| Average Basic Shares Outstanding | 375.50M | 370.90M | 369.60M | 372.00M | 368.40M |
| Average Diluted Shares Outstanding | 375.50M | 373.10M | 369.60M | 372.00M | 368.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |